BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28151874)

  • 21. ABCB1 variants confer susceptibility to primary open-angle glaucoma and predict individual differences to latanoprost treatment.
    Liu H; Yang ZK; Li Y; Zhang WJ; Wang YT; Duan XC
    Biomed Pharmacother; 2016 May; 80():115-120. PubMed ID: 27133047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan.
    Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB
    Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Two Polymorphisms, rs1045642 and rs1128503, in ABCB1 Following Taxane-based Chemotherapy: A Meta-Analysis.
    Chen Q; Lin W; Yang J; Lin M; Lin X; Weng Y; Chen Y
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):3-10. PubMed ID: 33507672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population.
    Xie WW; Zhang L; Wu RR; Yu Y; Zhao JP; Li LH
    Neuropsychiatr Dis Treat; 2015; 11():1967-71. PubMed ID: 26347319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between
    Tamimi DE; Abduljabbar R; Yousef AM; Saeed RM; Zawiah M
    Neurol Res; 2021 Sep; 43(9):724-735. PubMed ID: 33949294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis.
    Dong Y; Li P; Xu T; Bi L
    Clin Rheumatol; 2019 Jun; 38(6):1587-1594. PubMed ID: 30747393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
    Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
    Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between ABCB1 Polymorphisms and Cold Pain Sensitivity Among Healthy Opioid-naive Malay Males.
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Pain Pract; 2017 Sep; 17(7):930-940. PubMed ID: 27996183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of G protein-coupled receptor 65 gene are associated with ankylosing spondylitis in a Chinese Han population: A case-control study.
    Yuan Y; Ma Y; Zhang X; Han R; Hu X; Yang J; Wang M; Guan SY; Pan G; Xu SQ; Jiang S; Pan F
    Hum Immunol; 2019 Feb; 80(2):146-150. PubMed ID: 30529363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DOSAGE AND DURATION OF ETANERCEPT THERAPY FOR ANKYLOSING SPONDYLITIS: A META-ANALYSIS.
    Lee H; Jung Y; Song S; Lee J; Shim H; Kang W; Kim E
    Int J Technol Assess Health Care; 2017 Jan; 33(1):69-75. PubMed ID: 28434410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
    Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.
    Escudero-Vilaplana V; Ramírez-Herráiz E; Alañón-Plaza E; Trovato-López N; García-Vicuña R; Carreño-Pérez L; Morell-Baladrón A; Sanjurjo-Sáez M
    Int J Clin Pharm; 2015 Oct; 37(5):808-14. PubMed ID: 25910480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome.
    Li M; Xu M; Liu W; Gao X
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):14. PubMed ID: 29615122
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Shan XX; Qiu Y; Xie WW; Wu RR; Yu Y; Wu HS; Li LH
    Front Pharmacol; 2019; 10():761. PubMed ID: 31333472
    [No Abstract]   [Full Text] [Related]  

  • 35. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
    Fan YX; Zhang Z; Meng JR; Yin SJ; Wang P; Zhou T; Huang YH; Meng R; He GH
    Epilepsy Res; 2021 Nov; 177():106785. PubMed ID: 34653781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis.
    Huang Z; Cao J; Li T; Zheng B; Wang M; Zheng R
    Clin Exp Rheumatol; 2011; 29(4):642-9. PubMed ID: 21906429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease.
    Fehér Á; Juhász A; Pákáski M; Kálmán J; Janka Z
    J Mol Neurosci; 2014 Dec; 54(4):826-9. PubMed ID: 25273678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Am J Drug Alcohol Abuse; 2016 Sep; 42(5):587-596. PubMed ID: 27284701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).
    Poddubnyy D; Hermann KG; Callhoff J; Listing J; Sieper J
    Ann Rheum Dis; 2014 May; 73(5):817-23. PubMed ID: 24389297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.